COMPPARE Newsroom Prostate cancer research news
The latest information for patients.
News from around the world
A new combination therapy regimen shows promising results for prostate cancer
The combination of two oral medications has shown positive results in people with prostate cancer, whose disease has spread to other parts of the body. Compared with XTANDI plus placebo,…
Study describes the structural and functional effects of several mutations on the androgen receptor
The androgen receptor is a key transcriptional factor for the proper sex development — especially in males — and the physiological balance of all the tissues that express this receptor.…
Mediterranean diet the best prevention against prostate cancer
New research shows that men who stick to a predominantly Mediterranean diet are less likely to be diagnosed with prostate cancer. This diet also improves their chances of recovery if…
Long-term exposure to nitrate in drinking water may be a risk factor for prostate cancer
The nitrate ingested over the course of a person’s adult lifetime through the consumption of tap water and bottled water could be a risk factor for prostate cancer, particularly in…
News from COMPPARE
What’s Next for COMPPARE?
Patient accrual has closed. Now, it’s up to participants to continue to complete COMPPARE’s Quality of Life and Side Effects Follow-up…
COMPPARE Completes Patient Enrollment
After four years and 2,524 enrolled patients, the COMPPARE team officially closed patient accrual to the study on October 31, 2022 at 11:59 p.m…
COMPPARE Enrolls 1,000th Photon Patient
The COMPPARE Coordinating Center announced today that the study has enrolled its 1,000th photon prostate cancer patient to reach 67% of its photon…
